Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Intralipid

Generic name: I.v. fat emulsion

FDA application holder: Fresenius

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Intralipid?
Intralipid is a brand name of I.v. fat emulsion, a prescription medicine. The FDA NDC Directory lists 10 Intralipid products in 3 strengths and forms.
Who makes Intralipid?
Fresenius holds the FDA application for Intralipid (NDA017643, approved October 7, 1975). 3 other companies (repackagers or distributors) also list Intralipid products.
Is there a generic or store brand of Intralipid?
Other products of I.v. fat emulsion are listed with the FDA, but none in exactly the same strength and form as a Intralipid product.
Has Intralipid been recalled?
FDA enforcement reports list 3 recalls of Intralipid products; the newest started April 13, 2022. A recall usually concerns specific lots, not every product.

What Intralipid is

Each Intralipid product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

I.v. fat emulsion · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
soybean oil 10%
emulsion (intravenous)
Intralipid None listed DailyMed
soybean oil 20%
emulsion (intravenous)
Intralipid None listed DailyMed
soybean oil 30%
emulsion (intravenous)
Intralipid None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: I.v. fat emulsion →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Intralipid products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA017643FreseniusOctober 7, 19751
NDA018449FreseniusJanuary 23, 19816
NDA019942FreseniusDecember 30, 19932
NDA020248FreseniusAugust 7, 19961

Companies that list Intralipid

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Intralipid products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. April 13, 2022 · Class II · Terminated · D-1119-2022

    cGMP deviations: Temperature abuse

    Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09 — Mckesson Medical-Surgical Inc. Corporate Office

  2. April 13, 2022 · Class II · Terminated · D-1120-2022

    cGMP deviations: Temperature abuse

    Intralipid (I.V. Fat emulsion), 20%, 100 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-58 — Mckesson Medical-Surgical Inc. Corporate Office

  3. September 15, 2017 · Class I · Terminated · D-0030-2018

    Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility.

    Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden for Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0519-58 — Baxter Healthcare Corporation

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers